actogenix oral delivery peptides actobiotics
human growth hormone
small molecule her2 inhibitor
sports medicine doping
“trial and error” drug discovery process
March 19, 2014
By Marija (Masha) Zecevic
A piece in the latest issue of BioCentury tackles the pricing and reimbursement challenges faced by Soliris® as it emerges from the most recent negotiations between UK’s NICE and Alexion Pharmaceuticals. As of today, Soliris is the most expens...
Buzz words few spoke about 5 years ago
September 15, 2015
A New Perspective on my PhD
June 4, 2015
Are Human Embryonic Stem Cells now patentable in Europe?
January 7, 2015
How do Italian researchers feel about Technology Transfer Offices?
December 1, 2014
When Are False Positives Unacceptable?
May 14, 2014
Minutes from BioInItaly Start-Up Initiative 2014
April 2, 2014
Humans are ecosystems, just like the kefir yoghurt
March 23, 2014
The price and the cost of the most expensive drug ever – a debate based on speculation and lack of transparency
BioEurope Spring 2014 – My Favourite Company Presentation
March 14, 2014
Embracing the “Trial and Error” approach in drug discovery
March 13, 2014